Patterns and genomic correlates of PD-L1 expression in patients with biliary tract cancers

Kabir Mody, Jason S. Starr, Michelle Saul, +5

Journal of Gastrointestinal Oncology

Detection of microsatellite instability-high (MSI-H) by liquid biopsy predicts robust and durable response to immunotherapy in patients with pancreatic cancer

Sakti Chakrabarti, Leslie Bucheit, Jason S. Starr, +7

Journal for ImmunoTherapy of Cancer

Efficacy of Immune Checkpoint Inhibition and Cytotoxic Chemotherapy in Mismatch Repair-Deficient and Microsatellite Instability-High Pancreatic Cancer: Mayo Clinic Experience

Tucker Coston, Aakash Desai, Hani M. Babiker, +8

JCO Precision Oncology

Circulating Tumor DNA-Based Testing and Actionable Findings in Patients with Advanced and Metastatic Pancreatic Adenocarcinoma

Gehan Botrus, Heidi Kosirorek, Mohamad Bassam Sonbol, +14

The Oncologist

Follicular Dendritic Cell Sarcoma Presenting As a Thyroid Mass

Jason S. Starr, Steven Attia, Richard W. Joseph, +3

Journal of Clinical Oncology

Thyroid DiseaseHistopathologyPathologyThyroid DisordersThyroid Hormone +3

Outcomes on <scp>anti‐VEGFR</scp>‐2/paclitaxel treatment after progression on immune checkpoint inhibition in patients with metastatic gastroesophageal adenocarcinoma

Lionel Aurelien Kankeu Fonkoua, Sakti Chakrabarti, Mohamad Bassam Sonbol, +17

International Journal of Cancer

Cancer ImmunosurveillanceGastrointestinal OncologyMedicineMetastatic Gastroesophageal AdenocarcinomaImmunology +11

Cell-Free Tumor DNA Dominant Clone Allele Frequency Is Associated With Poor Outcomes in Advanced Biliary Cancers Treated With Platinum-Based Chemotherapy

Pedro Luiz Serrano Usón, Umair Majeed, Jun Yin, +27

JCO Precision Oncology

Onvansertib in Combination With Chemotherapy and Bevacizumab in Second-Line Treatment of <i>KRAS</i> -Mutant Metastatic Colorectal Cancer: A Single-Arm, Phase II Trial

Daniel H. Ahn, Maya Ridinger, Timothy Lewis Cannon, +15

Journal of Clinical Oncology

Pan-Cancer Prevalence of Microsatellite Instability-High (MSI-H) Identified by Circulating Tumor DNA and Associated Real-World Clinical Outcomes

Pashtoon Murtaza Kasi, Leslie Bucheit, Jiemin Liao, +12

JCO Precision Oncology

Circulating Cell-Free Tumor DNA in Advanced Pancreatic Adenocarcinoma Identifies Patients With Worse Overall Survival

Gehan Botrus, Pedro Luiz Serrano Usón, Puneet Raman, +14

Frontiers in Oncology